U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton)...
Category : Approval/Launch 6 August 2026Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of...
Approval Launch
Triquetra Health Launches BioActive Vitamin B1 Cli...
Category : Approval/Launch 4 August 2026New Supplement Combines High-Dose Benfotiamine with Essential Cofactors Triquetra Health has anno...
Dr. Reddy’s Zoliflodacin Gets Thai FDA Approval fo...
Category : Approval/Launch 28 July 2026Nuzolvence becomes a new oral antibiotic option for uncomplicated urogenital gonorrhea Dr. Reddy&...
Zydus Lifesciences Gets Approval for Phase 3 Trial...
Category : Approval/Launch 24 July 2026Study to evaluate oral desidustat in patients with sickle cell disease and anemia Zydus Lifescien...
Alembic Partner Natco Pharma Receives US FDA Tenta...
Category : Approval/Launch 21 July 2026Product to be manufactured by Natco Pharma and distributed by Alembic Pharmaceuticals in the US A...
Latest Newsletter Post
-
Takeda announces positive data from..
1 October 2026
-
Vanda Reports Positive Phase III Re..
30 September 2026
-
Airway Therapeutics Receives $1.9 M..
30 September 2026
-
Tolerance Bio Licenses TLB-33 From..
30 September 2026
-
Ascletis Reports Positive Phase I R..
29 September 2026
